Mechanisms And Targets Of Antibody-complement Interactions That Neutralize Malaria
Funder
National Health and Medical Research Council
Funding Amount
$647,977.00
Summary
Our project aims to identify immune mechanisms that neutralize malaria from the moment of inoculation by a mosquito, before infection can become established to prevent the development of malaria disease. Furthermore, we will discover specific targets of protective immune responses. We expect this project will provide major new advances in our knowledge of human immunity to P. falciparum malaria, one of the world’s most significant causes of mortality and morbidity, and we will use this knowledge
Functional Assays Of Immunity To Malaria In Pregnant Women
Funder
National Health and Medical Research Council
Funding Amount
$578,905.00
Summary
Pregnant women are highly susceptible to malaria due to the adhesion of infected erythrocytes to the placenta. Antibodies to these infected erythrocytes can block their placental adhesion and/or facilitate their clearance by immune cells, improving pregnancy outcomes. We aim at informing vaccine design by better understanding the placental adhesion mechanisms and identifying targets of protective immunity as well as antibody correlates of protection from placental malaria and its consequences.
Understanding The Development Of Humoral Immunity To Malaria Merozoites
Funder
National Health and Medical Research Council
Funding Amount
$642,804.00
Summary
We will examine the acquisition of antibody responses to various P. falciparum surface antigens and their association with reduced risk of re-infection and symptomatic malaria in a treatment re-infection study of children from a malaria endemic area of Papua New Guinea. The effector mechanisms by which protective antibodies control parasite burden will be idendify. Defining the antigenic targets and effector mechanisms of immunity is essential for developing anti-malarial vaccines.
This an integrated program of basic research on antigen discovery and immune mechanisms, and preclinical research on novel vaccine platforms, formulations or delivery systems for the rational design and clinical testing of a next generation vaccine against malaria. This interdisciplinary research fosters strong national and international links and offers the potential for significant economic benefit to Australia.
Malaria infects millions of people worldwide causing serious morbidity and mortality. However, individuals do not develop natural immunity to malaria even after years of exposure to the parasite. There have be a multitude of attempts to make a vaccine , with products going to clinical trials, but no vaccine is able to provide adequate protection for the long term. We recently showed that Plasmodium had evolved a mechanism to kill cells that protect in the long-term. This study will investigate t ....Malaria infects millions of people worldwide causing serious morbidity and mortality. However, individuals do not develop natural immunity to malaria even after years of exposure to the parasite. There have be a multitude of attempts to make a vaccine , with products going to clinical trials, but no vaccine is able to provide adequate protection for the long term. We recently showed that Plasmodium had evolved a mechanism to kill cells that protect in the long-term. This study will investigate the mechanism by which the parasite kill these cells, so that novel therapies can be designed.Read moreRead less
The Role Of Chemokine Networks In Severe Malaria And The Control Of Parasite Density
Funder
National Health and Medical Research Council
Funding Amount
$620,731.00
Summary
Two contributing factors have been identified as the main determinants of severe malaria: high parasite densities and host inflammatory responses. To date it is not clear whether inflammation is a cause or a consequence of high parasite densities. We have identified a new biomarker (IP-10) of disease severity in a malaria-endemic area of Papua New Guinea that is associated with high parasite densities. Here we will decipher the mechanisms by which IP-10 contributes to the development of high par ....Two contributing factors have been identified as the main determinants of severe malaria: high parasite densities and host inflammatory responses. To date it is not clear whether inflammation is a cause or a consequence of high parasite densities. We have identified a new biomarker (IP-10) of disease severity in a malaria-endemic area of Papua New Guinea that is associated with high parasite densities. Here we will decipher the mechanisms by which IP-10 contributes to the development of high parasite burden and severe malaria.Read moreRead less
T-follicular Helper Cell Subsets That Induce Protective Anti-Plasmodium Falciparum Antibodies
Funder
National Health and Medical Research Council
Funding Amount
$456,262.00
Summary
Malaria claims at least half a million lives each year, the majority of them in children under the age of 5 years. In order to development effective vaccines malaria it is critically important that we increase our understanding of the key mechanisms governing the induction of protective immune responses in naturally exposed populations. This project will examine the role of one important cell subset - T-follicular helper cells - in the development of immunity against malaria.
Immunological Prevention Of Cysticercosis And Hydatid Disease
Funder
National Health and Medical Research Council
Funding Amount
$567,868.00
Summary
Cysticercosis and hydatid disease are caused by infections with the larval stages of tapeworm parasites. They are life-threatening zoonotic diseases, transmitted to humans from animals and are most common in people living in poor countries. This project aims to develop practical vaccines to assist with the prevention of these diseases in humans. We will vaccinate the parasites' natural animal hosts and break the parasite life-cycles, thereby indirectly and inexpensively preventing the diseases b ....Cysticercosis and hydatid disease are caused by infections with the larval stages of tapeworm parasites. They are life-threatening zoonotic diseases, transmitted to humans from animals and are most common in people living in poor countries. This project aims to develop practical vaccines to assist with the prevention of these diseases in humans. We will vaccinate the parasites' natural animal hosts and break the parasite life-cycles, thereby indirectly and inexpensively preventing the diseases being passed to humans.Read moreRead less
Malaria In Pregnancy: Exposure, Immunity And Complications
Funder
National Health and Medical Research Council
Funding Amount
$549,723.00
Summary
Increasing malaria control efforts may lead to lack of exposure needed to develop immunity. We will use plasma samples from Africa, PNG and Asia, and measures of immunity we have developed, to discover (1) which are the most important protective immune responses and (2) how are these affected by changing exposure or new drugs. Overall, we hope to identify markers of protective immunity that can be used to identify women at most risk of malaria in pregnancy and its complications